Abstract
The methodologies of computational drug discovery and drug repositioning (DR) based on biomolecular profile information are reviewed systematically. For big data drug discovery and DR, 1) methods of comparing gene expression profiles of the diseased state and drug-administered state to predict the effect and toxicity of the drug, 2) DR methods based on the disease network, and 3) prediction of drug effect based on the biological network analysis are described. For methods of AI-based drug discovery, virtual screening using AI and AI-based drug target exploration are reviewed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
